Studie

International randomised controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma

Erkrankungsgruppe:

Solide Tumore

Organsystem:

Muskeln und Weichteile

Stadium:

Rückfall, Therapierefraktär

Standort:

Dortmund, Essen, Aachen

EudraCT:

2014-000259-99

Prüfplan-Code:

RG_13-277

Phase:

II/III

Prüfsubstanz:

Cyclophosphamide, Topotecan, Irinotecan, Temozolomide, Gemcitabine, Docetaxel, Ifosfamide

Sponsor:

University of Birmingham